ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 194,51
-0,87%
Dow Jones
44 860,31
0,28%
DAX
19 295,98
-0,59%
Brent Oil
72,36
-0,12%
Bitcoin
92 549,94
0,63%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Boundless Bio Inc (BOLD)

  7. Boundless Bio Inc (BOLD) Actualités

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BOLD
DateHeureSourceTitreSymboleSociété
25/11/202413h00GlobeNewswire Inc.Boundless Bio to Participate in the Piper Sandler Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
07/11/202422h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BOLDBoundless Bio Inc
07/11/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BOLDBoundless Bio Inc
07/11/202422h01GlobeNewswire Inc.Boundless Bio Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:BOLDBoundless Bio Inc
05/11/202413h00GlobeNewswire Inc.Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
14/10/202414h00GlobeNewswire Inc.Boundless Bio Announces Departure of Chief Financial OfficerNASDAQ:BOLDBoundless Bio Inc
11/09/202413h00GlobeNewswire Inc.Boundless Bio to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
21/08/202401h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BOLDBoundless Bio Inc
12/08/202422h01GlobeNewswire Inc.Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial ResultsNASDAQ:BOLDBoundless Bio Inc
05/06/202413h00Business WireBoundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
13/05/202413h00Business WireBoundless Bio Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:BOLDBoundless Bio Inc
06/05/202414h00Business WireBoundless Bio to Present at the Citizens JMP Life Sciences Conference 2024NASDAQ:BOLDBoundless Bio Inc
11/04/202414h00Business WireBoundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene AmplificationsNASDAQ:BOLDBoundless Bio Inc
08/04/202414h00Business WireBoundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024NASDAQ:BOLDBoundless Bio Inc
14/02/202023h23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
11/02/202022h41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
27/01/202015h38Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:BOLDBoundless Bio Inc
21/01/202012h00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
04/12/201901h13PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc.NASDAQ:BOLDBoundless Bio Inc
03/12/201900h01Business WireAstellas Enters into Definitive Agreement to Acquire Audentes TherapeuticsNASDAQ:BOLDBoundless Bio Inc
26/11/201922h01Business WireAudentes Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BOLDBoundless Bio Inc
12/11/201923h33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
07/11/201923h18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BOLDBoundless Bio Inc
07/11/201922h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
07/11/201922h01Business WireAudentes Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:BOLDBoundless Bio Inc
31/10/201912h00Business WireAudentes Therapeutics to Release Third Quarter 2019 Financial Results and Provide Corporate Update on Thursday, November 7, 2...NASDAQ:BOLDBoundless Bio Inc
05/10/201913h01Business WireAudentes Therapeutics Presents New Positive Data from ASPIRO, the Clinical Trial Evaluating AT132 in Patients with X-Linked M...NASDAQ:BOLDBoundless Bio Inc
05/10/201900h00Business WireAudentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
30/09/201914h00Business WireAudentes Announces Upcoming Presentations at the 24th International Annual Congress of the World Muscle Society, Including Ne...NASDAQ:BOLDBoundless Bio Inc
23/08/201922h03Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BOLDBoundless Bio Inc
 Showing the most relevant articles for your search:NASDAQ:BOLD

Dernières Valeurs Consultées

EU
PX4
SBF 120
EU
ORA
Orange
EU
AF
Air FranceKLM
NYSE
NKE
Nike
COIN
XRPUSD
Ripple
COIN
AVAXUSD
Avalanche
NASDAQ
AAPL
Apple
EU
PX1
CAC 40
EU
VIV
Vivendi
COIN
ETHUSD
Ethereum
COIN
SOLUSD
Solana
NYSE
MCD
McDonalds
COIN
BTCUSD
Bitcoin
EU
ACA
Credit Agricole
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés

BLACK FRIDAY

ADVFN

Célébrons nos 25 ans Est 1999-2024

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Cours Euronext en temps réel et illimités sur le site. Carnet d'ordres Euronext en direct